The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

AgomAb Therapeutics NV insider acquisitions

Company CIK 0002020932 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
AGMB · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate
90-day company acquisitions grouped by security, category, original code, and currency.
Type / codeReported securityTransactionsKnown purchase valueMissing amounts
PurchaseCode PCommon sharesNon-derivative · Currency not specified8311,1700

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Epstein David REpstein David RKnotnerus Tim JasperKnotnerus Tim JasperKemula Pierre Thadee VictorKemula Pierre Thadee VictorEpstein David R · October 8, 2026 · Purchase · Common sharesKnotnerus Tim Jasper · October 6, 2026 · Purchase · Common sharesKnotnerus Tim Jasper · October 5, 2026 · Purchase · Common sharesKemula Pierre Thadee Victor · October 6, 2026 · Purchase · Common sharesKemula Pierre Thadee Victor · October 6, 2026 · Purchase · Common sharesKemula Pierre Thadee Victor · October 6, 2026 · Purchase · Common sharesEpstein David R · October 6, 2026 · Purchase · Common sharesEpstein David R · October 5, 2026 · Purchase · Common sharesOct 5, 2026Oct 8, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

8 dated transactions · 3 of 3 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 8, 2026AgomAb Therapeutics NVCommon sharesEpstein David RPurchase
Oct 6, 2026AgomAb Therapeutics NVCommon sharesKnotnerus Tim JasperPurchase
Oct 5, 2026AgomAb Therapeutics NVCommon sharesKnotnerus Tim JasperPurchase
Oct 6, 2026AgomAb Therapeutics NVCommon sharesKemula Pierre Thadee VictorPurchase
Oct 6, 2026AgomAb Therapeutics NVCommon sharesKemula Pierre Thadee VictorPurchase
Oct 6, 2026AgomAb Therapeutics NVCommon sharesKemula Pierre Thadee VictorPurchase
Oct 6, 2026AgomAb Therapeutics NVCommon sharesEpstein David RPurchase
Oct 5, 2026AgomAb Therapeutics NVCommon sharesEpstein David RPurchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

AGMB · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: PurchaseCommon sharesNon-derivative security · Code P5,0008.9Value: 44,500Currency not specifiedView ↗
Trade:
Knotnerus Tim JasperChief Executive Officer · Director
PurchaseCommon sharesNon-derivative security · Code P5,0008.7Value: 43,500Currency not specifiedView ↗
Trade:
Knotnerus Tim JasperChief Executive Officer · Director
PurchaseCommon sharesNon-derivative security · Code P6,0008.48Value: 50,880Currency not specifiedView ↗
Trade:
Kemula Pierre Thadee VictorChief Financial Officer
PurchaseCommon sharesNon-derivative security · Code P2,0008.54Value: 17,080Currency not specifiedView ↗
Trade:
Kemula Pierre Thadee VictorChief Financial Officer
PurchaseCommon sharesNon-derivative security · Code P5,0008.57Value: 42,850Currency not specifiedView ↗
Trade:
Kemula Pierre Thadee VictorChief Financial Officer
PurchaseCommon sharesNon-derivative security · Code P3,0008.67Value: 26,010Currency not specifiedView ↗
Trade: PurchaseCommon sharesNon-derivative security · Code P5,0008.7Value: 43,500Currency not specifiedView ↗
Trade: PurchaseCommon sharesNon-derivative security · Code P5,0008.57Value: 42,850Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →